NCT07467265 The Rapid Shallow Breathing Index (RSBI) is a Widely Used Predictor for Weaning Patients From Mechanical Ventilation This Study Aims to Determine the Predictive Value of RSBI Measurements for Extubation Success in Mechanically Ventilated ICU Patients
| NCT ID | NCT07467265 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Ventilated Patient in Intensive Care |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2026-03-01 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Early extubation in ICU patients is crucial for reducing complications of prolonged ventilation, including morbidity and mortality. The Rapid Shallow Breathing Index (RSBI) is a widely used predictor for weaning patients from mechanical ventilation. This study aims to determine the predictive value of RSBI measurements for extubation success in mechanically ventilated ICU patients
Eligibility Criteria
Inclusion Criteria: * • Adults \> 22 years. * Mechanically ventilated patients meeting extubation readiness: * FiO₂ ≤ 0.4, PEEP ≤ 8 cmH₂O, PaO₂/FiO₂ ≥ 200 mmHg. * Respiratory rate ≤ 35 breaths/min, pH \> 7.30. * Hemodynamic stability (HR ≤ 120 bpm, SBP 90-160 mmHg). * Glasgow Coma Scale \>10, adequate cough reflex. * Includes postoperative, elective/emergency reintubation, and tracheostomized patients. Exclusion Criteria: * Age \<22 years. * Refusal of informed consent. * Altered mental status (e.g., traumatic brain injury). * Hemodynamic instability or deep sedation (RASS ≤ -2).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07467265 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, studying Ventilated Patient in Intensive Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07467265 currently recruiting?
Yes, NCT07467265 is actively recruiting participants. Contact the research team at sarahhamdy@med.asu.edu.eg for enrollment information.
Where is the NCT07467265 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07467265 clinical trial?
NCT07467265 is sponsored by Ain Shams University. The trial plans to enroll 70 participants.